
A new risk assessment tool, PVD-B65, was developed to predict one-year mortality in chronic lung disease and pulmonary hypertension patients. Key predictors included pulmonary fibrosis without emphysema, vascular resistance, six-minute walk distance, BNP levels, and age. The tool stratified patients into low, intermediate, and high-risk groups, showing significant survival differences.
Like
Save
Share